作者：
Justin Z,Wang [1]
;
Vikas,Patil [1]
;
Jeff,Liu [1]
;
Helin,Dogan [2]
;
Ghazaleh,Tabatabai [3]
;
Leeor S,Yefet [4]
;
Felix,Behling [5]
;
Elgin,Hoffman [6]
;
Severa,Bunda [7]
;
Rebecca,Yakubov [7]
;
Ramneet,Kaloti [7]
;
Sebastian,Brandner [8]
;
Andrew,Gao [9]
;
Aaron,Cohen-Gadol [10]
;
Jill,Barnholtz-Sloan [11]
;
Marco,Skardelly [12]
;
Marcos,Tatagiba [5]
;
David R,Raleigh [13]
;
Felix,Sahm [2]
;
Paul C,Boutros [14]
;
Kenneth,Aldape [15]
;
International Consortium on Meningiomas (ICOM) [16]
;
Farshad,Nassiri [17]
;
Gelareh,Zadeh
作者单位：
MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada.;Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada.;Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
[1]
Department of Neuropathology, University Hospital Heidelberg (DKFZ), Heidelberg, Germany.
[2]
Department of Neurosurgery, Center for Neuro-Oncology, Comprehensive Cancer Center, Eberhard Karls University Tübingen, Tübingen, Germany.;German Cancer Consortium (DKTK), DKFZ Partner Site Tübingen, Tübingen, Germany.;Cluster of Excellence (EXC 2180) "Image Guided and Functionally Instructed Tumor Therapies", Eberhard Karls University Tübingen, Tübingen, Germany.
[3]
Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada.
[4]
Department of Neurosurgery, Center for Neuro-Oncology, Comprehensive Cancer Center, Eberhard Karls University Tübingen, Tübingen, Germany.
[5]
Cluster of Excellence (EXC 2180) "Image Guided and Functionally Instructed Tumor Therapies", Eberhard Karls University Tübingen, Tübingen, Germany.
[6]
MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada.;Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
[7]
Division of Neuropathology, UCL Queen Square Institute of Neurology, London, UK.
[8]
Division of Laboratory Medicine and Pathobiology, University Health Network, Toronto, ON, Canada.
[9]
Department of Neurosurgery, Indiana University, Bloomington, IND, USA.
[10]
Division of Cancer Epidemiology and Genetics, Center for Biomedical Informatics and Information Technology, National Cancer Institute, National Institutes of Health, Gaithersburg, MD, USA.
[11]
Department of Neurology and Interdisciplinary Neuro-Oncology, Center for Neuro-Oncology, Comprehensive Cancer Center, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Tübingen, Germany.
[12]
Department of Radiation Oncology, Neurological Surgery, and Pathology, University of California San Francisco, San Francisco, CA, USA.
[13]
Department of Human Genetics, University of California Los Angeles (UCLA), Los Angeles, CA, USA.
[14]
Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
[15]
MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada. farshad.nassiri@mail.utoronto.ca.;Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada. farshad.nassiri@mail.utoronto.ca.;Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. farshad.nassiri@mail.utoronto.ca.
[16]
MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada. gelareh.zadeh@uhn.ca.;Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada. gelareh.zadeh@uhn.ca.;Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. gelareh.zadeh@uhn.ca.
[17]
DOI
10.1007/s00401-023-02571-3
PMID
37093270
发布时间
2024-09-19
换一批
换一批
